Skip to main content
. 2024 Nov 14;29(1):2424677. doi: 10.1080/13510002.2024.2424677

Figure 8.

Figure 8.

Summary of the main results from this study. Kresoxym-methyl, a strobilurin, and its mixture with boscalid, a SDHI, alter the mitochondrial function in human HepG2 cells: the OCR was decreased, the level of mitochondrial radical superoxide anion was increased, the ATP level was reduced, the ratio reduced/oxidized glutathione was decreased, with a consequent decrease in cell viability.